01—History
EPS (Diluted) History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- −$2.91
2 older moves run past ±150% (largest −1555.0%); point at, tap or drag across the bars to read one.
02—Ledger
EPS (Diluted), period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | −$2.91 | −1555.0% | 10-K | |
| FY2024 | $0.20 | −97.8% | 10-K | |
| FY2023 | $9.22 | −2.7% | 10-K | |
| FY2022 | $9.48 | +24.7% | 10-K | |
| FY2021 | $7.60 | +5.6% | 10-K | |
| FY2020 | $7.20 | +42.0% | 10-K | |
| FY2019 | $5.07 | +9.7% | 10-K | |
| FY2018 | $4.62 | +81.9% | 10-K | |
| FY2017 | $2.54 | −21.4% | 10-K | |
| FY2016 | $3.23 | +3.2% | 10-K | |
| FY2015 | $3.13 | +17.7% | 10-K | |
| FY2014 | $2.66 | +25.5% | 10-K | |
| FY2013 | $2.12 | +5.5% | 10-K | |
| FY2012 | $2.01 | −6.1% | 10-K | |
| FY2011 | $2.14 | +139.8% | 10-K | |
| FY2010 | −$5.38 | −409.2% | 10-K | |
| FY2009 | $1.74 | +122.3% | 10-K | |
| FY2008 | −$7.80 | — | 10-K |
03—Questions
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is Charles River Laboratories International's current eps (diluted)?
Charles River Laboratories International (CRL) annual eps (diluted) for 2025 was $-2.91, a 1555.00% decline from 2024. Charles River Laboratories International eps (diluted) for the quarter ending September 26, 2026 was $6.86.
What was Charles River Laboratories International's eps (diluted) in 2024?
Charles River Laboratories International annual eps (diluted) for 2024 was $0.20, a 97.83% decline from 2023.
What was Charles River Laboratories International's eps (diluted) in 2023?
Charles River Laboratories International annual eps (diluted) for 2023 was $9.22, a 2.74% decline from 2022.
- Company
- Charles River Laboratories International
- Ticker
- CRL
- Sector
- Healthcare
- Industry
- Services-Commercial Physical & Biological Research